Cannabinoid acid ester compositions and uses thereof
US12403114B2 · kind B2 · utility
0Cited by
9References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 12, 2020 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Jan 1, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a cannabidiolic acid ester. A variety of therapeutic applications in which the cannabinoid acid ester compounds and pharmaceutical compositions find use are also provided, including combination therapies using cannabinoid acid ester compounds and one or more additional therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.